Harvard Bioscience announced the appointment of Stephen DeNelsky to its Board of Directors.
Stephen DeNelsky brings 30 years of experience in the healthcare industry to the Board.
DeNelsky's expertise in financial strategy will be valuable for Harvard Bioscience's future.
Appointment of Stephen DeNelsky
Stephen DeNelsky appointed to Harvard Bioscience's Board of Directors, effective September 5, 2025.
Financial Expertise
DeNelsky has extensive experience in research, analysis, and valuation of equities in healthcare.
Industry Knowledge
Brings expertise in guiding life sciences companies on financial strategy and governance.
- Stephen DeNelsky's appointment signals a strategic move by Harvard Bioscience to strengthen its Board with financial expertise.
- The addition of a seasoned industry leader like DeNelsky is expected to contribute to long-term value creation and governance at Harvard Bioscience.
The appointment of Stephen DeNelsky to the Board of Directors enhances Harvard Bioscience's leadership team and reflects the company's commitment to strategic growth in the healthcare industry.